companydata.dkBioMed Invest ApS: Financial statements 2022
CVR: 29844925
BioMed Invest ApS (CVR 29844925) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 21,062 and a net result of DKK -877,690 compared with DKK 7,319,836 the year before. That is an increase of 8,461.8% compared with the year before. Equity amounted to DKK 7,751,703. The solvency ratio was 99.8%. The company had 2 employees in the financial year.
- Gross Profit
- 21,062 kr.
- Profit/Loss
- -877,690 kr.
- Equity
- 7,751,703 kr.
- Total Assets
- 7,764,596 kr.
- Employees
- 2
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | 21 t. | -878 t. | 7.8 mio. | 2 |
| 2021 | - | 246 | 7.3 mio. | 8.6 mio. | 1 |
| 2020 | - | 28 t. | 6 t. | 1.4 mio. | - |
| 2019 | - | -16 t. | 17 t. | 1.5 mio. | - |
| 2018 | - | -35 t. | -16 t. | 1.5 mio. | - |
Keep an eye on BioMed Invest ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
BioMed Invest ApS has published its annual report for 2021. Gross profit came to DKK 246, and the net result was DKK 7,319,836.
About BioMed Invest ApS
BioMed Invest ApS is a Danish company of the type Anpartsselskab based in Aalborg, founded in 2006. The company is registered under the industry Computerkonsulentbistand og forvaltning af computerfaciliteter. The management consists of Erling Henningsen. The company is owned by Erling Henningsen. In 2025, the company reported a gross profit of DKK 12,474 and a net result of DKK -80,320 compared with DKK 451,303 the year before. Equity amounted to DKK 8,740,167.